(Q37992696)

26 August 2017

0 references

The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer (English)

1 reference

26 August 2017

1 reference

1

Fred Saad

1 reference

26 August 2017

Klaus Pantel

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

1 March 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

8

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

321-331

1 reference

5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males

26 August 2017

cites work

1 reference

PSA testing: an evolving relationship with prostate cancer screening

21 January 2018

1 reference

Is prostate-specific antigen a valid surrogate end point for survival in hormonally treated patients with metastatic prostate cancer? Joint research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum

21 January 2018

1 reference

Biomarkers for prostate cancer.

21 January 2018

1 reference

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

21 January 2018

1 reference

A guide to the interpretation of serum prostate specific antigen levels

21 January 2018

1 reference

Prostate-specific antigen in clinical practice

21 January 2018

1 reference

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

21 January 2018

1 reference

Combined androgen blockade therapy can convert RT-PCR detection of prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) transcripts from positive to negative in the peripheral blood of patients with clinically localized pros

21 January 2018

1 reference

Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients

21 January 2018

1 reference

Percentage of the positive area of bone metastasis is an independent predictor of disease death in advanced prostate cancer

21 January 2018

1 reference

Denosumab in men receiving androgen-deprivation therapy for prostate cancer

21 January 2018

1 reference

Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response

21 January 2018

1 reference

Clinical benefit of zoledronic acid for the prevention of skeletal complications in advanced prostate cancer

21 January 2018

1 reference

Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer

21 January 2018

1 reference

Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid

21 January 2018

1 reference

Metastatic bone disease: clinical features, pathophysiology and treatment strategies

21 January 2018

1 reference

The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer

21 January 2018

1 reference

Biochemical markers and skeletal metastases

21 January 2018

1 reference

Molecular biology of bone metastasis

21 January 2018

1 reference

Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer

21 January 2018

1 reference

Circulating tumour cells in cancer patients: challenges and perspectives

21 January 2018

1 reference

Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression.

21 January 2018

1 reference

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

Metastasis suppressors alter the signal transduction of cancer cells

21 January 2018

1 reference

Cancer cell interactions with injured or activated endothelium

21 January 2018

1 reference

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

21 January 2018

1 reference

Circulating tumor cells: evolving evidence and future challenges

21 January 2018

1 reference

Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer

21 January 2018

1 reference

Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment

21 January 2018

1 reference

Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer.

21 January 2018

1 reference

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

21 January 2018

1 reference

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

Circulating tumor cells and circulating tumor DNA.

21 January 2018

1 reference

Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study

21 January 2018

1 reference

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data

21 January 2018

1 reference

Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience

21 January 2018

1 reference

Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate

21 January 2018

1 reference

Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial

21 January 2018

1 reference

Zoledronic Acid improves clinical outcomes when administered before onset of bone pain in patients with prostate cancer

21 January 2018

1 reference

Circulating tumor cells in prostate cancer: a potential surrogate marker of survival

21 January 2018

1 reference

External quality assurance of circulating tumor cell enumeration using the CellSearch® system: A feasibility study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FON.12.3

1 reference

26 August 2017

1 reference